Analysis: U.S. midterms dampen Big Pharma hopes for drug price policy change

Farma Darya

WASHINGTON, Nov 18 (Reuters) – The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want to weaken a new law that allows the government to negotiate drug prices, Republican strategists, policy experts and pharmaceutical executives say. Democratic President Joe Biden’s signature Inflation Reduction Act, which Democrats […]